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ABSTRACT 
 
The human immune system is capable of detecting and removing foreign invaders 
such as viruses, microorganisms, and other harmful materials. A key component of this 
immune response is leukocyte recruitment—a process, in which leukocytes travel from 
the bloodstream to the site of injury or infection. SIRPα, a protein mainly known to be 
expressed in myeloid leukocytes, has been shown to contribute to this process by 
regulating transendothelial migration (TEM)—leukocyte passage through the vascular 
endothelium. Interestingly, a recent study has detected low levels of SIRPα on surface of 
cultured endothelial cells. The aim of this study was to confirm endothelial expression of 
SIRPα and to investigate its role in leukocyte TEM. SIRPα expression on the endothelial 
cell was confirmed by immunofluorescence microscopy, indirect immunofluorescence 
and flow cytometry, and by western blot analysis. shRNA silencing  and function 
blocking antibodies were used to block the adhesive function of  SIRPα in an in vitro 
TEM assay under physiological shear flow conditions.  The interventions did not alter 
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leukocyte TEM and we conclude that SIRPα does not play a significant role in leukocyte 
TEM in vitro. 
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INTRODUCTION 
General review 
Humans and mammals possess a biologically advanced immune system that 
protects themselves from countless harmful pathogens such as viruses and bacteria. This 
host defense is composed of leukocytes that circulate throughout the entire cardiovascular 
system to detect foreign “invaders” such as pathogenic viruses and microorganisms and 
materials that are not “non-self” including injured tissues and dying and dead cells. This 
system is critical to host defense (Medzhitov & Janeway Jr, 2002a). 
Leukocytes, or white blood cells, circulate throughout the body and tissues to 
survey and communicate information that is critical for host defense and homeostasis. 
Leukocytes are generated from hematopoietic stem cells in the bone marrow and play a 
critical role through engulfment and destruction of foreign substances as well as removal 
of dead and damaged tissues and cells. There are several different types of leukocytes. 
Each has varying functions and morphologies. Despite their differences, leukocytes share 
a similar mechanism in infiltrating into tissue from blood vessels through a process 
known as transendothelial migration (TEM) or diapedesis. The goal of this thesis is to 
examine the expression and function of SIRPα in leukocyte TEM.  
 
Innate vs. Adaptive Immune Response 
 The human immune system can be divided into two general categories—innate 
and adaptive immunity. Innate immunity consists of cellular and biochemical defense 
mechanism that exist prior to infection or injury. The major components of innate 
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immunity are physical barriers, mediators of inflammation, complement proteins, and 
leukocytes—natural killer (NK) cells, macrophages, and neutrophils (Abbas, 2005). The 
leukocytes involved in innate immunity recognize structures that are common to 
microbes, but are unable to distinguish the minor differences between foreign particles. 
For instance, leukocytes possess pattern recognition receptors (PRRs)—host receptors 
that respond to pathogens by participating in signaling cascades. Various signals 
stimulate innate immune cells to destroy non-self particles by engulfment, while also 
activating further immunological response. This type of response is known as adaptive 
immunity (Bonneville, O’Brien, & Born, 2010). The common receptor types that 
neutrophils and macrophages recognize are toll-like receptors, mannose receptors, and G 
protein-coupled receptors.  After recognition, these leukocytes produce reactive oxygen 
species (ROS), nitric oxide, and enzymes to defend against foreign substances (Abbas, 
2005). Production and release of these molecules during innate immunity continue to 
activate leukocytes and trigger adaptive immunity. 
 Adaptive immunity enhances defensive capabilities to recognize and respond to 
great number of foreign particles and distinguish closely-related microbes (Abbas, 2005). 
The principal cells of adaptive immune system are lymphocytes and antigen-presenting 
cells. Adaptive immunity can be divided into two subcategories—cell mediated immunity 
and humoral immunity. Cell mediated immunity is mediated by T-lymphocytes that 
migrate to sites of infection via chemokines and adhesion molecules. Antigen-presenting 
cells capture foreign substances that fit into a cell surface molecule called major 
histocompatibility complex (MHC). Once this substance, known as antigen, is displayed 
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on MHC, T-lymphocytes can either attack or coordinate further immune responses (Rojo, 
Saizawa, Janeway, & Jr, 1989). Humoral immunity is mediated by B-lymphocytes and 
their production of antibodies that neutralize foreign antigens. Unlike T-lymphocytes, B-
lymphocytes recognize the native antigen form without the presentation through MHC-
antigen complex (Abbas, 2005). Through these lymphocytes and antigen-presenting cells, 
adaptive immunity utilizes its immunological memory to deliver fast and potent 
responses against pathogens that have been previously detected by the host. 
 
Acute vs. Chronic Inflammation 
The recruitment of leukocytes and plasma proteins from the bloodstream into 
targeted tissues is referred to as inflammation. Inflammation is often described as either 
acute or chronic. Acute inflammation occurs over minutes to hours to a few days, while 
chronic inflammation can occur from several days to months or even longer (Luscinskas 
& Gimbrone, 1996). Neutrophils are the first type of leukocytes to reach the site of acute 
inflammation. Neutrophils, also known as polymorphonuclear granulocytes, act as 
proinflammatory agents through engulfment of pathogens, secretion of proteases, and 
production of inflammatory cytokines and attractants that recruit additional neutrophils 
(Witko-Sarsat, Rieu, Descamps-Latscha, Lesavre, & Halbwachs-Mecarelli). Neutrophils 
have a relatively short life and die within 24 hours after recruitment into the tissue or 
sooner if they engage foreign material and become activated. If the inciting foreign 
material is not removed or inactivated, the inflammation persists, and is considered 
‘chronic.’ During chronic inflammation, the recruitment of monocytes, T-lymphocytes, 
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and activated B cells (called plasma cells) begins to occur. While this response is 
considered self-limiting under normal conditions, certain immunological disorders lead to 
a continuous and disordered inflammatory response (Ferrero-Miliani, Nielsen, Andersen, 
& Girardin, 2007). 
 
Endothelium as an active player in leukocyte recruitment 
The vascular endothelium is a continuous, single thickness layer of cells that line 
the inner surface of the entire cardiovascular system (Lim et al., 1998). Under normal 
conditions, the vascular endothelium is a non-adherent surface, and leukocytes and 
platelets are unable to bind to the endothelium. This thin monolayer of cells is mostly 
known for its barrier function and contributions to blood pressure and hemostasis. 
Endothelial cells play a critical role to provide a localized response in vascular tone. 
Through production and release of molecules that either constrict (vasoconstrictors) or 
relax (vasodilators) the blood vessel, endothelium regulates blood circulation (Deanfield, 
Halcox, & Rabelink, 2007).  
During an inflammatory response, however, the endothelial cell surface changes 
dramatically to provide a localized response. Proinflammatory mediators such as TNF-α 
and bacterial endotoxins (LPS) increase vascular permeability by weakening endothelial 
cell junctions, thus making the blood vessels more ‘leaky’ (Vestweber, Winderlich, 
Cagna, & Nottebaum, 2009). Inflammatory stimuli, such as TNF-α, IL-1β, IFN-γ and 
other soluble factors, activate vascular endothelium to upregulate surface adhesion 
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molecules and secrete and display attractants (chemokines and chemoattractants) that 
recruit leukocytes into tissues (Luscinskas & Gimbrone, 1996).  
Three classes of receptor proteins interact as adhesion molecules during leukocyte 
recruitment—integrins, selectins, and Ig-like molecules. Each of these molecules plays a 
specific function in a multistep cascade process of leukocyte recruitment (Williams, 
Azcutia, Newton, Alcaide, & Luscinskas, 2011). 
The vascular endothelium acts as a zip code that is read by a variety of circulating 
leukocytes that possess specific integrins and receptors for endothelial selectin molecules. 
Upon activation, the upregulation of adhesion molecules and chemokines act in concert 
to facilitate cell-cell adhesion. Through this integration, the endothelium mediates 
leukocyte adhesion in a very selective manner, allowing controlled delivery of the right 
leukocyte type to only the inflamed or damaged target tissue (Luscinskas & Gimbrone, 
1996). 
 
Leukocyte recruitment 
As shown in Figure 1, the initial interaction in leukocyte recruitment is selectin-
mediated rolling (Step 1). Through weak binding between E-, P-, or L-selectin with their 
ligands, leukocyte rolling takes place. For instance, P-selectin glycoprotein-1 (PSGL-1) 
on leukocytes binds to endothelial expressed P- and E- selectin to initiate leukocyte 
contact and rolling on the apical endothelial cell surface (Luscinskas & Gimbrone, 1996).  
This weak interaction slows down the leukocyte rolling velocity from 1000 micron/sec to 
under 10 microns/sec, which leads to the second step—leukocyte activation via 
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chemokines and chemoattractants that bind to their respective receptors (Lawrence & 
Springer, 1991). One of the major proinflammatory cytokines produced by activated 
macrophages is tumor necrosis factor- α (TNF-α), which activates gene transcription 
pathways in the endothelium at sites of infection or injury to express adhesion molecules 
such as E-selectin, intercellular adhesion molecule-1(ICAM-1) and vascular cell adhesion 
molecule-1(VCAM-1) and chemokines such as interleukin-8 (IL-8). The production of 
inflammatory cytokines attracts leukocytes toward the endothelium before migrating to 
the site of injury (Wittchen, 2009). IL-8 and other chemoattractants are presented by 
glycoprotein scaffold structures on endothelial apical surface and contribute to the switch 
from low affinity selectin-mediated rolling interactions to high affinity, integrin-mediated 
adhesion. This high affinity adhesion, often known as firm adhesion, is the third step of 
the recruitment process. The firm adhesion of neutrophils onto the endothelium is 
mediated by leukocyte expressed integrin molecules interacting with endothelial 
expressed ICAM-1 and VCAM-1. Leukocyte β1 and β 2 integrins, such as VLA-4 and 
LFA-1, interact with endothelial ICAM-1 and VCAM-1, respectively, to induce firm 
adhesion of leukocytes (Wittchen, 2009).  
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1. Rolling
3. Firm adhesion
2. Leukocyte activation via chemokines
4. Transendothelial Migration
 
Figure 1. The multistep adhesion cascade. “Figure amended from Williams et al., 2011”. 
 
Transendothelial migration 
After firm adhesion, leukocytes undergo what is known as ‘locomotion’ to crawl 
over the apical surface of the endothelium through their LFA-1 and VLA-4 integrins. 
Then, leukocytes transmigrate across the endothelium either paracellularly or 
transcellularly, as shown in Figure 2 (Step 4). Paracellular migration is when a leukocyte 
travels between the lateral junctions of endothelial cells lining the blood vessel. 
Transcellular migration, on the other hand, indicates a movement through the body of an 
individual endothelial cell (Williams et al., 2011). 
 
8  
Paracellular Transmigration Transcellular Transmigration
Neutrophil Neutrophil
Figure 2. Transendothelial migration: paracellular vs. transcellular. “Figure amended 
from Williams et al., 2011”.  
 
This last step of leukocyte recruitment is a tightly regulated process because 
excessive or dysregulated TEM can lead to chronic inflammatory diseases including 
rheumatoid arthritis, atherosclerosis, and multiple sclerosis (Wittchen, 2009). 
Accordingly, it is important to comprehend this tightly regulated process in order to 
design therapeutic solutions in many pathologic conditions.  
Cell Adhesion Molecules 
Interestingly, previous studies have shown that paracellular transmigration is 
preferred over the transcellular route (Carman & Springer, 2004). In order for this 
paracellular transmigration to occur, endothelial cells are known to create openings based 
on a number of complex interactions between adhesion and signaling molecules 
(Vestweber et al., 2009). A major player involved in this process is vascular endothelial 
cadherin (VE-Cad), a protein known to contribute to adhesion and stability of endothelial 
junctions. Phosphorylation of the cytoplasmic region of VE-Cad has been shown to 
weaken the cell-cell junctions (Yap, Crampton, & Hardin, 2007). Therefore, VE-Cad 
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regulates both vascular permeability and regulation of leukocyte transmigration 
(Orsenigo et al., 2012). 
Other essential adhesion molecules such as ICAM-1 and CD47 are expressed on 
apical surface and can be enriched at cell-cell junctions. While both ICAM-1 and CD47 
have shown to regulate leukocyte transmigration, the extensive interactions of various 
cell adhesion proteins are still poorly understood (Zen & Parkos, 2003). 
 
Signal Regulatory Protein Alpha (SIRPα) 
 One group of cell surface proteins that interact with adhesion proteins is the signal 
regulatory proteins (SIRP). SIRPs, composed of transmembrane glycoprotein, belong to 
the immunoglobulin superfamily (IgSF) (A. N. Barclay & Brown, 2006). The first 
member identified was SIRPα, and was initially called protein tyrosine phosphatase, non-
receptor type substrate 1 (PTPNS1) (A. N. Barclay & Brown, 2006). SIRPα is expressed 
by neurons, smooth muscle cells, and myeloid cells including neutrophils, basophils, and 
eosinophils (Hatherley, Graham, Harlos, Stuart, & Barclay, 2009).   
 
Structure of SIRPα 
 SIRPα is a 90kDa transmembrane glycoprotein that consists of an intracellular or 
cytoplasmic domain and an extracellular domain. The cytoplasmic domain of SIRPα 
contains tyrosine residues that conform to an immunoreceptor tyrosine-based inhibition 
(ITIMs) motif. This motif functions as an inhibitory signal when its tyrosine residues are 
dephosphorylated by tyrosine phosphatases such as SHP-1 and SHP-2 (Long, 2008).  The 
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extracellular region of SIRPα is comprised of three immunoglobulin domains. The 
immunoglobulin superfamily is a group of proteins that recognize and bind to different 
types of ligands (A.Neil Barclay, 2003). Among these ligands, CD47 displays high 
affinity to bind to SIRPα. Figure 3 illustrates the receptor-ligand interaction between 
SIRPα and CD47.  
Plasma membrane
3 Extracellular IgSF domains
Cytoplasmic domain
inhibitory signal through phosphatases
 
Figure 3. Receptor-ligand interaction between SIRPα & CD47. “Figure amended from A. 
Neil Barclay, 2009”.  
 
CD47 (Integrin-Associated Protein) 
 CD47, or Integrin Associated Protein, was initially discovered because it 
copurified with β3 integrins (E. J. Brown & Frazier, 2001). CD47 has been shown to 
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interact with different surface protein receptors including other integrins, 
thrombospondin, and members of the SIRP family (Legrand et al., 2011).  
 CD47 is expressed by all cell types and participates in both “in cis” and “in trans” 
interactions with its ligands (E. J. Brown & Frazier, 2001). When cell surface receptors 
interact with ligands expressed on the same cell, the interaction is called ‘cis.’ On the 
other hand, an interaction is described as ‘trans’ if cell surface receptors bind to ligands 
on neighboring cells (Held & Mariuzza, 2011).  
CD47 is also known as a marker of self, and thus regulates macrophage 
phagocytosis (Medzhitov & Janeway Jr, 2002b). Many pathogens or foreign particles are 
phagocytosed by macrophage due to lack of this ‘marker.’ As CD47 binds to SIRPα in 
trans, it sends a ‘don’t- eat-me’ signal to distinguish itself from “non-self” (Oldenborg et 
al., 2000).  
 
CD47-SIRPα interactions 
The extracellular domain of SIRPα binds to CD47 and allows transmission of 
signals through its cytoplasmic ITIMs. The dimensions of SIRPα are compatible for 
binding “in trans” to CD47 (Hatherley et al., 2009).  CD47-SIRPα interactions have a 
variety of functions in human physiology. For instance, the CD47 - SIRPα interactions 
have been shown to be important in antigen-dependent activation of T-lymphocytes upon 
interaction with dendritic cells in in vitro studies  (Seiffert et al., 2001). Furthermore, 
there has been a keen interest in developing cancer therapeutic agents by targeting the 
CD47-SIRPα interaction. Research shows that animals unable to engage SIRPα 
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inhibitory signaling struggle to eliminate tumor cells (Zhao, Kuijpers, & Van den Berg, 
2012). Other reports emphasize the existence of SIRPα in podocytes and CD47 in the 
kidney glomerulus. Their data also illustrates that phosphorylation levels in the 
cytoplasmic region of SIRPα are reduced in diseased kidney, suggesting a role of SIRPα 
in renal physiology (Kurihara, Harita, Ichimura, Hattori, & Sakai, 2010). 
While this fascinating interaction between CD47-SIRPα plays a variety of roles, 
my particular interest was to address whether it functions in endothelium during 
leukocyte TEM.  In the brain endothelium, CD47-SIRPα interactions have been shown to 
mediate monocyte transendothelial migration (De Vries et al., 2002). When anti-CD47 
mAb was applied on endothelial cells to block CD47-SIRPα interaction, TEM was 
reduced by 46%. Also, applying anti-SIRPα mAb on monocytes reduced the number of 
monocytes that transmigrated. This shows that the CD47-SIRPα interactions certainly 
play a role in regulating leukocyte transmigration.  
  
CD47- SIRPγ interaction 
CD47 is known to bind both SIRPα and SIRPγ (A. Neil Barclay, 2009). While 
myeloid cells have been shown to express SIRPα, T and B-lymphocytes express SIRPγ 
(A. N. Barclay & Brown, 2006). Since both myeloid cells and lymphocytes express 
CD47, it is generally thought that “in trans’ interactions occur within these cells.  
Our lab has published work that demonstrates the importance of CD47-SIRPγ 
interaction in human endothelium. As mentioned earlier, CD47 is expressed at cell-cell 
borders as a junctional surface protein. T-lymphocytes (T-cells) have been shown to 
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express SIRPγ, but not SIRPα. On the other hand, high levels of SIRPα and very low 
amount of SIRPγ were detected in neutrophils (Stefanidakis, Newton, Lee, Parkos, & 
Luscinskas, 2008a).  
The interaction between endothelial CD47 and T-cell’s SIRPγ was examined in 
vitro under flow conditions in order to accurately mimic the condition of activated human 
endothelium and the transendothelial migration. When function blocking antibodies are 
used to inhibit the interaction between CD47 on endothelium and SIRPγ on T-cells, 
transendothelial migration was reduced by 70%. While TEM had a remarkable reduction 
in quantity, the firm adhesion of T-cells on endothelial cells seem to remain unaffected 
(Stefanidakis et al., 2008a). 
 
Discovery of SIRPα on endothelium 
 The expression of SIRPα has been studied mainly in myeloid cells and neurons. 
Interestingly, our lab has found a low level of SIRPα in human umbilical vein endothelial 
cells (HUVEC) (Stefanidakis et al., 2008a), and others have shown its expression in 
murine endothelial cells (Johansen & Brown, 2007). Despite this striking observation, the 
role of endothelial SIRPα in leukocyte recruitment has not been examined yet.  
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SPECIFIC AIMS 
The vascular endothelium plays a crucial role in leukocyte recruitment during 
inflammation. The final step of recruitment process, TEM, is leukocyte passage through 
the endothelium, mediated by adhesion and signaling molecules. While many of these 
adhesion and signaling proteins have been identified on vascular endothelial cells 
already, their intricate interactions are still poorly understood.  
In this thesis, I have examined one of the signaling molecules, SIRPα, to better 
comprehend the role that it plays in leukocyte recruitment. Specific Aim 1 will confirm 
the surface expression of SIRPα in human vasculature cells in blood vessels in human 
tissues and in cultured HUVEC by multiple techniques. Specific Aim 2 will then address 
the function of SIRPα expressed on HUVEC in leukocyte TEM using an in vitro chamber 
model that mimics blood flow conditions in postcapillary venules. I hypothesize that the 
SIRPα expressed on HUVEC plays a significant role in leukocyte TEM.  
 
Specific Aim 1. Detect surface expression of SIRPα on HUVEC and human endothelial 
tissues. 
a) Visualize SIRPα expression in human vascular endothelial cell in human tissues 
and in cultured HUVEC by immunofluorescence microscopy. 
b) Visualize and quantify endothelial expressed SIRPα in western blots. 
c) Visualize and quantify surface expression of SIRPα on HUVEC, using flow 
cytometry. 
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Specific Aim 2. Investigate the function of endothelial expressed SIRPα in TEM. 
a) Examine whether SIRPα blocking mAb reduces TEM via in vitro chamber assay. 
b) Examine whether SIRPα knockdown via shRNA transfection reduces TEM via in 
vitro chamber assay and flow cytometry. 
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MATERIALS AND METHODS 
Reagents 
DPBS, with calcium and magnesium (DPBS
+
) and without (DPBS
−
), Medium 199 
(M199), trypsin-versene, and HBSS were purchased from Lonza (Hopkinton, MA). 
Human recombinant TNF-α was purchased from PeproTech (Rocky Hill, NJ). IFN-γ and 
IL-1β were obtained from R&D systems (Minneapolis, MN). Fugene transfection reagent 
was obtained from Roche (Indianapolis, IN). Oligonucleotides, Optimem, DMEM, and 
FCS were purchased from Life Technologies (Carlsbad, CA). TBS, tween-20, and 
isopropanol (100%) were purchased from Thermofisher (Waltham, MA). Ethanol was 
from Decon Labs (King of Prussia, PA). 4% Paraformaldehyde, LPS, and polybrene were 
purchased from Sigma-Aldrich (St. Louis, MO).  
 
Antibodies 
Rabbit polyclonal antibody against the cytoplasmic tail of SIRPα (catalog #1125) 
was obtained from ProSci (Poway, CA). Murine monoclonal antibody to domain 3 of 
SIRPα (SAF4.2) was a kind gift of Dr. Charles Parkos (Emory University, Atlanta, GA). 
Hec-1 mAb recognizes human VE-Cad and was the kind gift of Dr. William Muller 
(Northwestern University, Evanston, IL). Anti-MHC class I (W6/32) mAb was purchased 
from American Type Culture Collection (ATCC) (Manasass, VA), and anti–ICAM-1 
function blocking (HU5/3) mAb was described previously (Lim et al., 1998). Alexa 488-
conjugated goat anti-mouse and Alexa 647–conjugated goat anti–mouse antibodies were 
from Life Technologies (Carlsbad, CA). HRP conjugated secondary antibodies, goat anti-
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mouse and goat anti-rabbit, were from Promega (Madison, WI) (Stefanidakis, Newton, 
Lee, Parkos, & Luscinskas, 2008b). 
 
Human endothelial cell isolation and culture 
HUVEC were isolated  from two to five umbilical cord veins, pooled together, 
and grown to confluence in Medium 199 containing 20% FCS, endothelial cell growth 
factor, porcine intestinal heparin, and antibiotics (Luscinskas, Brock, Arnaout, & 
Gimbrone, 1989). Subcultures of HUVEC were seeded onto 0.1% gelatin coated cell 
culture dishes with addition of hydrocortisone (18.1μg/ml) and ascorbic acid (8.8mg/ml). 
After approximately 48 hours of culture, the HUVEC monolayers had reached confluence 
and were ready for experiments (Allport, Muller, & Luscinskas, 2000).  
 
Histology 
 Frozen human cardiac tissue obtained at autopsy was cut into 5μm thick sections 
using a cryostat. The tissue was collected onto a glass slide and was fixed in ice-cold 
acetone. After fixation, it was blocked with 1% bovine serum albumin in PBS at room 
temperature for one hour. Next, the tissues were incubated with primary antibodies 
(8µg/ml) at room temperature for 1 hour. A specific monoclonal antibody SAF4.2 stained 
a unique epitope human SIRPα, while CD31 was used as a specific marker of human 
endothelial cells. Isotype matched antibody, mouse IgG, functioned as a negative control 
to estimate nonspecific binding. After washing with PBS, tissue sections were incubated 
with biotinylated secondary antibodies (5μg/ml) at room temperature. The tissue was then 
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incubated with HRP-avidin-biotin complex solutions at 1:1:1000 dilutions (Vector 
Laboratories, Burlingame, CA). Then, 3-amino-9-ethylcarbazole (Vector Laboratories, 
Burlingame, CA) was used as a substrate of HRP to detect specific antibody binding. As 
the target complex is conjugated with a peroxidase, the substrate, 3-amino-9-
ethylcarbozole, was oxidized to produce reddish-brown color. A hematoxylin solution 
(Polysciences, Warrington, PA) was used to  counterstain the tissue, providing contrast to 
improve visualization of the brown staining (Grabie et al., 2003).  
 
Neutrophil isolation 
 Neutrophils were isolated from the blood of normal healthy human volunteers. 
Blood was drawn into CCD anticoagulant buffer (9 volumes of blood to 1 volume of    
100mM sodium citrate plus 130mM glucose at pH 6.5), mixed well, layered over 
histopaque and centrifuged for 10 minutes at 1,200rpm at room temperature. After 
removing the platelet-rich plasma from the top of the blood, the cell pellet was diluted 1:3 
in HBSS. Through further centrifugation, neutrophils were separated from other blood 
cells on lymphocyte separation medium (Litton Biometics, Kensington, MD) (Bevilacqua, 
Pober, Wheeler, Cotran, & Gimbrone, 1985).  
 
Flow Cytometry 
 Flow cytometry is a technique used in many laboratories because of its ease to 
perform, yet powerful technology to sort and classify cell populations according to size, 
surface expression of cell type markers, and complexity (Srivastava et al., 2013). A 
robust aspect of this technology is its ability to detect with fluorochrome-combined 
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markers or antibodies (Othmer & Zepp, 1992). The flow cytometer shines a laser beam of 
monochromatic light onto suspended cells, exciting the fluorochrome molecules to a 
higher energy state. As these molecules return to the resting state, fluorochromes emit 
light signals (photons) in all directions. Multiple fluorescent detectors then collect and 
convert these signals into electrical output for data analysis (M. Brown & Wittwer, 2000).  
For my project, I labeled cells with antibodies conjugated to fluorescent dyes to 
detect surface expression of specific proteins such as SIRPα and ICAM-1 in HUVEC. 
Furthermore, flow cytometry provided a method for analyzing and confirming 
knockdown of SIRPα protein in HUVEC as described later in sections on siRNA 
transfection and lentiviral transfection.  
 Flow cytometry staining was performed on HUVEC under resting conditions. 
HUVEC were trypsinized to create a single cell suspension and the cells collected onto a 
96-well plate by centrifugation at 4 degrees Celsius. As an isotype control, supernatant 
K1616 mAb was used to display background staining. SAF4.2 as purified IgG was used 
as a primary antibody to the extracellular domain of SIRPα. Alexa 647–conjugated goat 
anti–mouse (1/200 dilution) was used to detect binding of primary antibody (anti-SIRPα). 
After fixing the cells with 1% formaldehyde, analysis of cell fluorescence was performed 
in a fluorescence-activated cell scanner (FACScan) instrument (BD Biosciences, San 
Jose, CA). FlowJo software was used to analyze and generate figures from the collected 
data.  
 
Immunofluorescence microscopy 
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 Immunofluorescence staining of human endothelial cells was performed to 
confirm the presence of SIRPα. First, endothelial cells were seeded onto fibronectin 
coated glass cover-slips and cultured to confluence. HUVEC were washed in DPBS- and 
fixed with 4% paraformaldehyde at room temperature for ten minutes. Cover-slips were 
blocked in DPBS+ with 1% goat serum, 1% horse serum, and 1% salmon testes DNA for 
one hour at 4 degrees Celsius. SAF4.2 was then added in 1:50 dilution for an hour. After 
washing with DPBS-three times, cells were treated with a secondary antibody—Alexa 
488, goat anti-mouse antibody, for another hour. After washing, directly conjugated Hec-
1 antibody was used to stain VE-Cad in order to detect cell-cell junctions. Finally the 
stained samples were sealed on a glass slide to be analyzed by fluorescence microscopy. 
Using MetaMorph v5.0 software (Molecular Devices, Downingtown, PA), live cell 
imaging was performed through digital fluorescence imaging system with an inverted 
microscope (model TE2000; Nikon, Melville, NY)  and fluorescence lamp system (Sircar 
et al., 2007). 
 
Western blot of SIRPα 
 In order to confirm the detection of SIRPα in cultured vascular endothelium, 
western blots were performed. Western blot is a technique that detects and quantifies 
protein size and amount and its reaction through immunological procedures (Towbin, 
Staehelin, & Gordon, 1979). In this project, we aimed to detect expression of SIRPα 
protein in cultured human endothelial cells. To obtain the sample, we used detergent lysis 
buffer and collected the HUVEC lysate in reducing sample buffer. A 10% sodium 
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dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) gel (Bio-Rad, 
Hercules, CA) was loaded with a multi-color sample marker and HUVEC lysate samples. 
Gel electrophoresis was performed at 200V for an hour. The gel was covered with a 
nitrocellulose membrane (Whatman Schleicher and Schuell, Dasel, Germany), using a 
wet transfer technique. Proteins were transferred from the PAGE to the membrane by 
electrical current (90 minutes at 250 milliamps at 4 degrees Celsius). The membrane was 
then blocked for an hour in 5% milk powder dissolved in TBS containing 0.05% Tween. 
The blocking step reduces nonspecific background staining of the membrane. The 
membrane was incubated in primary antibody, SAF4.2 (15.6μg) over night at 4 degrees 
Celsius. The following morning, HRP-conjugated goat anti–mouse IgG (1/5000 dilution) 
was used to detect the protein of interest. Then, the blot was developed by the Enhanced 
ChemiLuminescence (ECL) System (Pierce Biotechnology, Rockford, IL) in the dark 
room.  
Surface biotinylation is a common method used to target expression of surface 
molecules, using a reagent that can restrict labeling to the cell surface (Emerman, Zhang, 
Chakrabarti, & Hegde, 2010). In order to label only extracellular surface proteins, 
biotinylation of HUVEC monolayers was carried out at 4 degrees Celsius to prevent 
internalization of the biotin labeling agent (GE Healthcare, Pittsburg, PA). Biotin is a 
linker molecule with extremely high affinity to a protein named streptavidin (DeChancie 
& Houk, 2007). By utilizing the strong affinity of these molecules, the protein of interest 
on HUVEC surface was detected with high specificity. 
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Gene Silencing via Transfection 
 Transfection is a process of introducing new genetic materials into host cells via 
viral or nonviral protocols (Gutierrez, Lemoine, & Sikora, 1992). One type of such gene 
delivery is virus-induced gene silencing, an effective mechanism to silence, or 
knockdown, a specific gene of interest (Ma, Yan, Huang, Chen, & Zhao, 2012). In my 
project, knockdown of SIRPα protein was accomplished first by nonviral transfection to 
select the best target sequence for optimal silencing, and then this sequence was cloned 
into the lentiviral vector. Through flow cytometry, the extent of SIRPα knockdown via 
siRNA transfection and lentiviral transfection was quantified. These approaches to 
disrupt protein expression are the cutting edge approaches to examine the role of SIRPα 
in neutrophil recruitment using an in vitro flow chamber assay that mimics the 
physiological levels of shear flow of postcapillary venules. 
 
siRNA transfection 
Using Lipofectamine RNAiMAX (Life Technologies, Carlsbad, CA), small 
interfering RNA (siRNA) was introduced into cells to knock down SIRPα protein 
expression via lipofection. Lipofection is a process in which a positively charged 
liposome vesicle fuse with the negatively charged nucleic acids to allow genetic materials 
to travel across the cell plasma membrane and into the cytoplasm of quiescent and 
proliferating cells (Dalby et al., 2004).  
siRNA was diluted in Optimem (3.75µl in 250µl Optimem) medium. 
Lipofectamine RNAiMAX was diluted as well (5µl in 250µl Optimem). Diluted siRNA 
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was mixed into diluted Lipofectamine RNAiMAX reagent and incubated for 15 minutes 
at room temperature. The siRNA/RNAiMAX complex then was transferred to HUVEC 
cultures. After 72 hours of transfection, HUVEC were subjected to flow cytometry 
staining as described above to quantify the knockdown of SIRPα surface protein.    
 
 Lentiviral transfection 
In order to perform lentiviral transfection, lentiviruses had to be designed and 
developed with a correct vector insert. shRNA vector was constructed according to a 
protocol from Westerman, Ao, Cohen, & Leboulch (2007). First, oligonucleotides were 
annealed using a sense target sequence (GCTGAGAACACTGGATCTAAT) 
recommended by Life Technologies to silence SIRPα expression in cells. Then, the 
plasmids from Dr. Westerman were digested with restriction enzymes to allow for 
insertion of annealed oligonucleotides. Through ligation and digestion, plasmids were 
modified to ensure appropriate knockdown of the gene of interest.  
Through transformation, a process in which bacteria take up and incorporate 
exogenous genetic material, the vector was replicated into many copies. A batch of 
colonies of bacteria took up the vector insert and was grown in Petri dishes. The plasmids 
from these bacteria were purified using a commercial plasmid prep kit (Life Technologies, 
Carlsbad, CA). The plasmids were subjected to restriction enzyme digest and separated 
on agarose gel electrophoresis to confirm the correct insertion of the oligonucleotides.  
Cells used for lentiviral expression were human embryonic kidney 293T 
(Westerman, Ao, Cohen, & Leboulch, 2007). These cells were maintained with DMEM 
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containing 10% FCS and penicillin-streptomycin. Twenty-four hours prior to transfection, 
the 293T cells were split (1:4 ratio) onto plastic cell culture dishes. Lentiviral transfection 
was performed, using Fugene transfection reagent. First, DNA mixture was made by 
combining the shRNA and four essential plasmids (HPV 275, p633, HPV601, and YN15). 
Then, Fugene reagent was added to the mixture for 15 minutes of incubation. The 
mixture was added to culture medium with 293T cells (Westerman et al., 2007). After 48 
hours of transfection, the medium with transfected cells was collected via 10ml syringe 
and filtered through a 0.22µm Millex syringe filter, finally obtaining the lentivirus. In 
order to determine optimal concentrations for the virus, I infected HUVEC with different 
dilutions of virus from 50 to 100 µL per 1ml. Polybrene (8µg/ml) was also added to 
increase the efficiency of virus infection. Polybrene, a cationic polymer, is known to 
neutralize electrostatic repulsion, allowing viruses to effectively reach and contact the 
cell surface of host cells (Davis, Rosinski, Morgan, & Yarmush, 2004). After 120 hours 
of infection, I collected the endothelial cells and performed flow cytometry staining to 
quantify the level of SIRPα knockdown.  
After confirmation of the knockdown, a concentrated virus was made according to 
Dr. Westerman’s protocol (Westerman et al., 2007). Transfection was done (just like in 
regular virus collection) on 20 plastic culture dishes of 293T cells. Supernatants from 
293T cells were collected, as described earlier, using a syringe with Millex filter. The 
supernatants were centrifuged for two hours in a SW 28 Rotor at 24,000rpm. The 
supernatant was discarded and the pellet was resuspended gently in 500µl buffer and was 
aliquoted and stored at -80 degrees Celsius. After addition of polybrene (8µg/ml), 
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HUVEC were infected with concentrated lentiviruses (2µl/ml). After 120hours of 
infection, flow cytometry was performed to quantify the knockdown of SIRPα. 
 
Neutrophil transmigration assay under flow 
Glass cover-slips were cleaned with isopropanol followed by ethanol and placed 
in empty C6 wells. Then, the coverslips were incubated with 1ml of fibronectin (5µg/ml) 
for 24 hours. The HUVEC were added to the coverslips and after 48 hours of culture 
HUVEC were confluent and were stimulated by addition of TNF-α (10ng/ml) 
(Stefanidakis et al., 2008b).  
For the in vitro flow chamber assay after SIRPα knockdown, HUVEC were 
seeded onto plastic cell culture wells. After 24 hours, cells were infected with SIRPα 
shRNA or control shRNA lentivirus along with the addition of polybrene (8µg/ml) to 
enhance cell uptake of virus. The next day, HUVEC were refed with fresh media. The 
day before the assay, the monolayers were trypsinized to remove cells from the culture 
flask and aliquoted onto fibronectin-coated glass coverslips. Cell were allowed to attain 
confluence for use in our studies 
Each coverslip was inserted into a parallel plate flow chamber for the adhesion 
and transmigration assay at 37 degrees Celsius. The parallel plate flow chamber consists 
of two steel plates that are separated by a 250µm thick silastic gasket (Dow Corning, 
Midland, MI). The flow channel was made after removing 5 x 50mm rectangular section 
of the gasket. Flow was created by a syringe pump (Harvard Apparatus, Natick, MA) that 
26  
is drawn across the HUVEC monolayer. Freshly isolated neutrophils were resuspended in 
flow buffer (10
6
 cells in 100μl of DPBS+ with 0.1% human serum albumin) and drawn 
through the flow chamber as a bolus at 1 dyne/cm
2
 (Alcaide et al., 2012). The shear flow 
was then reduced to 0.2 dyne/cm
2
 for 1 minute to allow neutrophils to accumulate in the 
field of view. Once there were about 40-80 neutrophils in the field of view, flow was 
increased to 0.75 dynes/cm
2
 for a 10-minute period.  
Using MetaMorph v5.0 software (Molecular Devices, Downingtown, PA), an 
image was captured every 10 seconds, taking a total of 61 live cell images. An inverted 
microscope (model TE2000; Nikon, Melville, NY) with a PlanApo 20× differential 
interference contrast (DIC) objective and a high-sensitivity camera (ORCA-ER; 
Hamamatsu, Bridgewater, NJ) was used to capture images. These images were processed 
into a time lapse movie using MetaMorph software. The movies were viewed and 
analyzed via ImageJ v1.31 software. Selected images in the paper represent multiple 
experiments with different leukocyte donors and HUVEC cultures to account for 
variability. The percentage of transendothelial migration was calculated, using the 
following equation: total transmigrated neutrophils/[total adhered + transmigrated T 
cells] × 100 (Stefanidakis et al., 2008b).  
 
Statistical analysis 
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Statistical significance was tested using an unpaired t-test, using GraphPad Prism 
software. Data were concluded to be statistically significant only when the p-value was 
lower than 0.05.  
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RESULTS 
Detection of SIRPα in human vascular endothelial cells and in cultured HUVEC 
 Previous reports have shown that SIRPα is expressed at low levels in cultured 
murine endothelial cells (Johansen & Brown, 2007). There are no publications to date 
that have determined whether human endothelium in intact blood vessels express SIRPα 
protein. My first experiment was to stain human cardiac and lung tissue obtained with 
IRB approval from autopsy tissue for expression of SIRPα. As described in ‘Methods,’ 
immunohistochemical staining was performed on human tissue to detect SIRPα antigen 
in human blood vessels. Serial 5μm thick sections of cardiac tissue were stained with a 
specific monoclonal antibody SAF4.2 to detect SIRPα. Figure 4 (a) clearly shows the 
SIPRα specific mAb stains endothelial cells that line intact blood vessels (brown 
reactivity identified by black arrows).  We used a positive control mAb, anti-CD31 (also 
called PECAM-1), which is a specific marker for vascular endothelial cells in the other 
serial section of this tissue (EC identified by arrows). There is clear overlap of SIRPα 
staining and CD31 staining, confirming that SIRPα is expressed by human endothelial 
cells in intact blood vessels of the heart. Similar results for SIRPα and CD31 
colocalization were seen in blood vessels of the lung (data not shown). In addition, 
SIRPα staining was also detected in vascular smooth muscle cells and in lung epithelial 
cells. Mouse IgG showed little, if any, specific staining and serves as a negative control 
for antibody staining specificity.  
In Figure 5, immunofluorescence staining of cultured human umbilical vein 
endothelium (HUVEC) was performed as described in ‘Methods.’ In addition to 
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confirming the presence of SIRPα in endothelium, I was interested to examine the 
localization of SIRPα protein. Previous reports have shown that CD47 is enriched at 
endothelial cell-cell borders (Stefanidakis et al., 2008b), which is also the location where 
leukocyte often transmigrate. Therefore, I speculated that SIRPα would also be enriched 
at cell-cell junctions. I stained HUVEC with a specific antibody that detects vascular 
endothelial cadherin (VE-Cad), a protein that localizes exclusively to endothelial cell-cell 
borders in vivo and in vitro (Allport et al., 2000), and hence would identify the cell-cell 
borders. Although there is an overlay of SIRPα and VE-Cad (shown in Figure 5), SIRPα 
did not localize exclusively at cell-cell borders. While VE-Cad staining is clearly 
outlining the cell borders, some non-specific staining in the cell nuclei was believed to be 
an artifact of staining because VE-cad has not been reported to localize to the nucleus. 
To corroborate the immunohistochemical analysis of cultured endothelium and 
intact blood vessels, western blotting of SIRPα in resting HUVEC was performed as 
described in ‘Methods.’ The aim of this western blot was to detect the presence of the 
protein. SIRPα migrated in SDS-PAGE as a broad ~90kDa band by western blot (Figure 
6). This broad band of antibody immunoreactivity suggests that the protein is 
glycosylated. Both the molecular mass and broadness of the smear are consistent with 
previous reports of western blot analysis of SIRPα in human neutrophils (Lee et al., 
2010). In Figure 6(a), primary antibody (SAF4.2) binding on streptavidin-biotinylated 
cell surface was detected via HRP secondary antibody (goat anti-mouse). In Figure 6(b), 
regular western blot was performed using rabbit polyclonal antibody (SIRPα #1125 from 
ProSci) to detect SIRPα at the C-terminal end. 
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The last method used to detect surface expressed SIRPα in HUVEC was indirect 
immunofluorescence followed flow cytometry. In Figure 7, different aliquots of SAF4.2 
antibody were tested for their ability to stain SIRPα efficiently. Except the oldest aliquot, 
SAF4.2-1, all of the aliquots demonstrated satisfactory detection level of surface 
expression of SIRPα on HUVEC. The intensity differences between aliquots were 
relatively insignificant. The K1616 monoclonal antibody was used as an isotype control 
to account for any nonspecific staining. ICAM-1 monoclonal antibody (HU5/3) was used 
as a positive control by confirming surface expression of ICAM-1 on HUVEC.  
 
Influence of cytokines on SIRPα expression in HUVEC 
 As mentioned in ‘Introduction,’ proinflammatory cytokines activate vascular 
endothelium to upregulate expression of cell surface molecules at the level of gene 
transcription. After detecting SIRPα expression on endothelial cell surface, I was 
interested whether various proinflammatory cytokines would alter its surface expression 
levels.  Figure 8 shows an analysis done by flow cytometry to determine if changes in 
SIRPα expression occur after cytokine or LPS treatments. HUVEC were treated with 
TNF-α (10ng/ml), IFN-γ (10ng/ml), IL-1β (10ng/ml), a combination of IL-1β (10ng/ml) 
and IFN-γ (10ng/ml), and LPS (1mg/ml) for four or twenty-four hours. While there 
seemed to be a small shift in intensity of SIRPα after the treatments, the differences did 
not reach statistical significance.  
The validity of stimulation of endothelium was confirmed by staining of ICAM-1. 
After treatment with cytokines and LPS, the expression of ICAM-1 displayed a 
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significant increase in expression. For instance, ICAM-1 showed the greatest increase in 
expression after TNF-α treatment, which is very consistent with past studies that revealed 
TNF-α upregulation of ICAM-1 surface expression in HUVEC (Pober et al., 1987). 
Figure 8 also highlights lack of expression of SIRPγ in HUVEC. This is consistent with 
previous published data from the Luscinskas lab (Stefanidakis et al., 2008b). 
 
In vitro chamber flow assay with function blocking monoclonal antibodies 
 After SIRPα expression on the endothelial surface was confirmed, I next wanted 
to test for its role in TEM. In order to determine whether SIRPα has an impact on TEM, I 
decided to disrupt its receptor-ligand interaction with CD47 via function blocking 
antibodies. Utilizing the in vitro flow chamber model described in ‘Methods,’ in vitro 
chamber assays under flow were conducted with function blocking monoclonal 
antibodies. For cells to adhere onto endothelium in the first place, HUVEC were treated 
with TNF-α (10ng/ml) 4 hours before the assay.  Figure 9 is an image taken by the video-
microscopy system that captures a particular field of the HUVEC monolayer. After 
neutrophils had adhered (black arrows) to the activated endothelium, images were taken 
to identify neutrophils that transmigrated (shown in red).  
Using ImageJ software, the percent (%) of cell transmigrating was calculated by 
counting total number of adhered neutrophils and number of neutrophils that 
transmigrated. There were four conditions to determine whether blocking SIRPα’s 
function would affect neutrophil transmigration. TNF-α only condition confirmed that 
cytokine activation of the HUVEC induced neutrophil adhesion and transmigration. Anti-
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Class I (W6/32) monoclonal antibody was used as a negative control and showed that a 
mAb bound to a molecule not involved in TEM does not affect TEM. Since ICAM-1 is 
involved as a endothelial component of TEM, anti-ICAM-1 (HU5/3) antibody was used 
as a positive control. While function blocking antibody for SIRPα (SAF4.2) did decrease 
the percentage of transmigrated neutrophils, the difference was not statistically 
significant as compared to anti-Class I (W6/32) monoclonal antibody. Figure 10 shows a 
bar graph that averages four separate trials of in vitro chamber assay.  
 
SIRPα knockdown via siRNA transfection 
 Since the initial in vitro flow chamber assay with function blocking antibodies 
suggested SIRPα was not involved in leukocyte TEM, I chose a second approach to 
corroborate the antibody studies and used siRNA transfection to silence SIRPα in 
HUVEC. As described in ‘Methods,’ the gene was silenced via Lipofectamine 
RNAiMAX complex, and flow cytometry was performed to confirm the knockdown. As 
shown in Figure 11, SIRPα was knocked down by 84%. Although the overall knockdown 
percentage was satisfactory, there was a significant population of cells (shown by a peak 
that overlaps the control siRNA treated cells) that did not get transfected.  
 
SIRPα knockdown via Lentiviral transfection 
 In order to improve SIRPα knockdown, lentiviral transfection was performed, as 
described in ‘Methods.’ After optimizing viral infection conditions and selecting a 
plasmid (#8) that produced the greatest knockdown, a concentrated virus stock was 
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produced, as mentioned in ‘Methods.’ Figure 12 illustrates concentrated virus #8’s 
performance in knocking down SIRPα by > 90 % after 120 hours of infection.  
 
In vitro flow chamber assay with lentiviral transfection 
 After confirming SIRPα knockdown in HUVEC through flow cytometry, an in 
vitro flow chamber assay was performed to examine whether knocking down SIRPα 
would reduce TEM. Figure 13 shows a bar graph that averages four separate trials of in 
vitro chamber assay with different conditions. The assay and analysis were performed as 
described earlier in this section. The main difference from the previous assay was the 
shRNA transfection (control and SIRPα) in HUVEC. Although the endothelial cells that 
received SIRPα shRNA transfection demonstrated slightly decreased fraction of 
neutrophil transmigration, the difference was not statistically significant from the control 
shRNA. As shown before in Figure 9, anti-ICAM-1 antibody showed statistically 
significant reduction in TEM once again. 
34  
RESULTS-FIGURES 
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Figure 4. Detection of SIRPα in human blood vessels of heart 
 
In Figure 4(a), SIRPα is clearly stained in human endothelial cells. The mouse 
monoclonal antibody used to stain SIRPα was SAF4.2. The positive control is CD31 
(specific for PECAM-1), staining endothelial cells in Figure 4(b). The staining technique 
is included in the methods section. In Figure 4(c), purified mouse IgG, which shows no 
reactivity, was used as the negative control. 
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Figure 5. Immunofluorescent staining of SIRPα in HUVEC 
 
HUVEC were stained as described in ‘Methods.’ In Figure 5(a), SIRPα was stained using 
primary antibody (SAF4.2) and secondary antibody (Alexa488). A directly conjugated 
antibody Hec-1 was used to stain VE-Cad in Figure 5(b). White arrows indicate cell-cell 
staining by VE-Cad mAb. Using Image J software, SIRPα staining and VE-Cad staining 
were superimposed, as shown in Figure 5(c). Secondary only (Alexa488) serves as a 
negative control, displaying any non-specific staining in Figure 5(d). 
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Figure 6. SIRPα surface expression detected by Western Blot 
 
In Figure 6(a), After SIRPα immunoprecipitation, HUVEC were surface biotinylated and 
then detected with HRP-conjugated antibody. In Figure 6(b), SIRPα was 
immunoprecipitated from the HUVEC lysates, and the material was blotted for SIRPα 
using a polyclonal antibody that recognizes the C-terminal domain. In both Figure 6(a) 
and 6(b), a broad band stains SIRPα around 90KDa (marked with an arrow). 
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Figure 7. Surface expression of SIRPα detected by flow cytometry  
 
SIRPα was stained on HUVEC, as described in ‘Methods.’ Isotype K1616 was used as a 
negative isotype-matched control. ICAM-1 monoclonal antibody HU5/3 was used as a 
positive control, shown in light blue. Aliquots #1 through 9 are aliquots (1.3mg/ml) of 
SAF4.2 antibody obtained from Dr. Charles Parkos. 
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Figure 8. Influence of proinflammatory cytokines or LPS on surface expression of SIRPα  
 
In red, HUVEC were stained without incubation with proinflammatory cytokines or LPS. 
In blue, HUVEC received 4 hour treatments of either TNF-α (10ng/ml), IFN-γ (10ng/ml), 
IL-1β (10ng/ml), or a combination of IL-1β (10ng/ml) and IFN-γ (10ng/ml), or LPS 
(1µg/ml). In green, HUVEC were treated with above cytokines or LPS for 24 hours.  
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(a) 
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Figure 9. Transendothelial migration of neutrophils 
 
The vascular endothelium was stimulated by TNF-α (10ng/ml) for 4 hours without any 
function blocking antibodies or virus infection. Black arrows indicate neutrophils that are 
firmly adhered. The yellow arrows are pointing at neutrophils that are in the process of 
transmigrating. Portions of the neutrophils that are underneath the monolayer are 
indicated by white triangles. Red arrows point at neutrophils that have completed 
transendothelial migration and are beneath the monolayer. Figure 9(b) is a magnified 
image of the same field identified by the black box.  
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Figure 10. Analysis of in vitro flow chamber assay under flow with function blocking 
antibodies 
 
TNF-α only condition stimulated the endothelium, allowing neutrophils to firmly adhere 
and transmigrate. All other conditions received four hours of TNF-α as well. Class I was 
blocked with W6/32. ICAM-1 was blocked with HU5/3. SIRPα was blocked with 
SAF4.2. The percentage of neutrophil transmigration with ICAM-1 blocking antibody 
was significantly lower compared to blocking Class I (p<0.05). However, the difference 
in percentage of neutrophil transmigration between Class I and SIRPα was not 
statistically significant (p<0.05) by the Student’s t test. 
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Figure 11. SIRPα knockdown via siRNA (transient) transfection 
 
Flow Cytometry and siRNA transfection were performed as described in the ‘Methods’ 
section. The SAF4.2 monoclonal antibody was used to detect surface expression of 
SIRPα in HUVEC. In red, K1616 supernatant antibody was used to function as an isotype 
matched control. In light blue, SIRPα expression was detected in HUVEC that did not 
receive transfection. In dark green, leftward shift (knockdown) in SIRPα expression is 
shown after siRNA transfection. It was noted that there were two subpopulations, one 
that got the knockdown and the other that was not. When the former subpopulation was 
isolated, the knockdown percentage turned out to be 83.7%.  
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Figure 12. SIRPα knockdown via shRNA (lentiviral) transfection 
 
Flow Cytometry and shRNA transfection were done as described in ‘Methods.’ 
Concentrated viruses (2µL/ml) were used to infect HUVEC with incubation time of 120 
hours. The SAF4.2 monoclonal antibody was used to detect surface expression of SIRPα 
in HUVEC. In red, K1616 supernatant antibody was used to function as an isotype 
control. In light blue, SIRPα expression was detected in HUVEC that received control 
shRNA. Control lentivirus was used to determine any off-target effects of shRNA 
transfection. In orange, the leftward shift indicates knockdown of SIRPα by shRNA 
transfection. The knockdown percentage was calculated to be 93%. 
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Figure 13. Analysis of in vitro flow chamber assay under flow with shRNA transfection 
and function blocking antibody 
 
TNF-α treatment of endothelium promotes neutrophils to firmly adhere and transmigrate. 
All other conditions received four hours of TNF-α as well. Control shRNA transfection 
was done as a negative control, and as expected, this treatment did not reduce TEM. The 
ICAM-1 blocking antibody was included to see if reduction in TEM can be noted, as in 
previous assays with blocking antibodies. The percentage of neutrophil transmigration 
with ICAM-1 blocking antibody was significantly lower compared to control shRNA 
transfection (p<0.05). However, the difference in percentage of neutrophil transmigration 
between control shRNA and SIRPα shRNA was not statistically significant (p<0.05) by 
the student’s t test. 
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DISCUSSION 
Significance of SIRPα Expression in EC 
 
 As mentioned earlier, SIRPα has been thought to be mainly expressed in myeloid 
cells, muscle and neurons (A. N. Barclay & Brown, 2006). Through multiple methods 
(immunofluorescence microscopy, western blot, and flow cytometry), the surface 
expression of SIRPα in endothelial cells has been confirmed (as shown in Figure 5, 7, & 
8). This discovery led to further scientific inquiries to examine the vascular 
endothelium’s critical role in inflammation. Convincing evidence over the past two 
decades have shown that endothelial cells actively participate in leukocyte recruitment 
through a number of cell surface adhesion molecules (Luscinskas et al., 1989). The 
addition of endothelial expressed SIRPα to this unique, intricate relationship between 
endothelium and leukocytes should be recognized as a step forward in comprehending the 
inflammatory response as a whole.  In addition, while this project addresses EC’s specific 
role in TEM, endothelial expressed SIRPα should be further examined for other 
functions. Even though expression level of SIRPα is fairly low, the presence of this 
multi-functional protein cannot be ignored. 
 
Influence of cytokineson SIRPα expression 
 Figure 8 shows the lack of influence of proinflammatory cytokines or endotoxin 
(LPS) on SIRPα expression, and therefore suggests SIRPα’s expression is most likely not 
regulated by the most common proinflammatory cytokines or LPS. This is vastly 
different from other EC surface proteins such as ICAM-1 and Class I, which require gene 
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transcription by proinflammatory cytokines for their expression. This implies that SIRPα 
can function, and possibly assist leukocyte recruitment, in spite of being unresponsive to 
inflammatory cytokines.  
 
Function blocking monoclonal Antibodies 
 Previous studies have shown that when SIRPα expressed on leukocyte is blocked 
with mAb, it cannot interact with endothelial CD47 and there is a decrease in leukocyte 
TEM (De Vries et al., 2002). Therefore, I tested whether the reverse is true by blocking 
endothelial expressed SIRPα with monoclonal antibody (SAF4.2) from interacting with 
its counter receptor CD47 expressed on neutrophils. The experiment produced a 
statistically insignificant difference in neutrophil TEM between blocking Class I and 
blocking SIRPα. This result, therefore, seemed insufficient to reveal SIRPα’s role in 
TEM. One possible explanation is the relatively low level of SIRPα expression on 
endothelial cell surface. Therefore, attempting to block a low level of protein expression 
could have been challenging via monoclonal blocking antibodies.  
 
siRNA vs shRNA transfection 
For the most extensive SIRPα protein silencing, both siRNA and shRNA 
transfection were performed. siRNA is a transient transfection that silences the gene of 
interest without being incorporated in a virus form. Instead, lipofection, as described in 
‘Methods,’ utilizes a vesicle composed of phospholipid bilayers to reach the site for 
transfection (Dalby et al., 2004). Although this type of transfection seems fairly effective 
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in most cases, it has its limitations. For instance, transient transfection shows lack of 
integration into host genome compared to retroviral transfection. In addition, lipofection 
may be cytotoxic if the lipid components accumulate (Van Tendeloo, Van Broeckhoven, 
& Berneman, 2001).  Therefore, I also pursued lentiviral (shRNA) transfection to knock 
down SIRPα to a greater extent. Lentivirus is a subset of retroviruses that has shown 
efficiency in gene delivery due to its unique ability to infect and integrate naturally with 
non-dividing cells. With its high efficiency of infection, lentivirus has been shown to 
provide long-term treatment in previous studies (Nayerossadat, Maedeh, & Ali, 2012). 
Concordant with the theory, Figure 12 displays the superior effectiveness of lentiviral 
transfection over transient transfection in SIRPα knockdown. This process of 
development and optimization of shRNA transfection from this project will continue to 
make its contributions in the field of human pathology. 
 
In vitro flow chamber assay with lentiviral transfection 
After SIRPα knockdown via shRNA transfection, in vitro flow chamber assay 
results showed that silencing SIRPα did not significantly reduce TEM. The SIRPα 
knockdown was certainly successful, as shown in flow cytometry data (Figure 12).  
Therefore, SIRPα does not play a regulatory role in TEM in this in vitro assay carried out 
under shear flow conditions that mimic blood flow in postcapillary venules, the site of 
leukocyte transmigration in vivo.  Although our original hypothesis is not supported by 
our results, the discovery of endothelial expressed SIRPα should prompt further studies to 
reveal its potential functions.   
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